Item does not contain fulltextOBJECTIVE: To determine the optimum excision margin and nodal management for patients with primary cutaneous melanomas 2.01- to 4.00-mm thick (T3 melanomas). BACKGROUND: Currently available evidence does not reliably define the minimum safe excision margin and best nodal management for patients with primary cutaneous T3 melanomas. METHODS: A retrospective study was conducted, analyzing data on 1587 patients with melanomas 2.01- to 4.00-mm thick treated at a single center. RESULTS: A histopathologic excision margin of 8 mm or more (equivalent to a >/=1 cm surgical margin) was associated with increased local and in-transit recurrence-free survival [hazard ratio (HR) = 0.54; P = 0.008] and disease-free survival (D...
Purpose of Review: The main surgical treatment for invasive malignant melanoma consists of wide surg...
The incidence of melanoma is rapidly increasing worldwide and the prognosis of patients with metasta...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
OBJECTIVE: To determine the optimum excision margin and nodal management for patients with primary c...
OBJECTIVE: This study was designed to determine the minimum safe pathologic excision margin for prim...
OBJECTIVE: To quantify the impact of excision margins on disease-specific survival of patients with ...
Background: The optimal surgical excision margins are uncertain for patients with thick (>2 mm) loca...
Thirty years ago, most melanomas were widely excised with 3-cm to 5-cm margins, and many centers tre...
SummaryBackgroundThe necessary margin of excision for cutaneous melanomas greater than 2 mm in thick...
Background: In the past there has been controversy concerning the necessary margin of excision for c...
The surgical management of malignant melanoma historically called for wide excision of skin and subc...
Introduction: Definitive management of primary cutaneous melanoma consists of surgical excision of t...
BACKGROUND Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 m...
Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melan...
Background The necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness i...
Purpose of Review: The main surgical treatment for invasive malignant melanoma consists of wide surg...
The incidence of melanoma is rapidly increasing worldwide and the prognosis of patients with metasta...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
OBJECTIVE: To determine the optimum excision margin and nodal management for patients with primary c...
OBJECTIVE: This study was designed to determine the minimum safe pathologic excision margin for prim...
OBJECTIVE: To quantify the impact of excision margins on disease-specific survival of patients with ...
Background: The optimal surgical excision margins are uncertain for patients with thick (>2 mm) loca...
Thirty years ago, most melanomas were widely excised with 3-cm to 5-cm margins, and many centers tre...
SummaryBackgroundThe necessary margin of excision for cutaneous melanomas greater than 2 mm in thick...
Background: In the past there has been controversy concerning the necessary margin of excision for c...
The surgical management of malignant melanoma historically called for wide excision of skin and subc...
Introduction: Definitive management of primary cutaneous melanoma consists of surgical excision of t...
BACKGROUND Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 m...
Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melan...
Background The necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness i...
Purpose of Review: The main surgical treatment for invasive malignant melanoma consists of wide surg...
The incidence of melanoma is rapidly increasing worldwide and the prognosis of patients with metasta...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...